Literature DB >> 12026224

Gadolinium-loaded nanoparticles engineered from microemulsion templates.

Moses O Oyewumi1, Russell J Mumper.   

Abstract

Microemulsions (oil-in-water) have been used as templates to engineer stable emulsifying wax and Brij 72 (polyoxyl 2 stearyl ether) nanoparticles. The technique is simple, reproducible, and amenable to large-scale production of stable nanoparticles having diameters below 100 nm. Investigation of the process variables showed that the amount of surfactant used in the preparation of microemulsion templates had the greatest influence on the microemulsion window, as well as the properties and stability of the cured nanoparticles. Emulsifying wax and Brij 72 nanoparticles (2 mg/mL) made with 3 mM polyoxyl 20 stearyl ether and 2.3mM polysorbate 80, respectively, were the most stable based on retention of nanoparticle size over time. Gadolinium acetylacetonate (GdAcAc), a potential anticancer agent for neutron capture therapy (NCT), was entrapped in stable nanoparticles. The apparent water solubility of GdAcAc was increased more than 2000-fold by entrapment into nanoparticles. The entrapment efficiency of GdAcAc was about 100% for emulsifying wax nanoparticles and 86% for Brij 72 nanoparticles, as determined by gel permeation chromatography (GPC). Elution profiles were obtained with light scattering (counts per second) to detect nanoparticles and ultraviolet (UV) absorption of GdAcAc at 288 nm. Challenges of these cured nanoparticles in biologically relevant media such as 10% fetal bovine serum, 10 mM phosphate-buffered saline, 150 mM NaCl, and 10% lactose at 37 degrees C for 60 min demonstrated that these nanoparticles are stable. The ease of preparation of these very small and stable nanoparticles, and the ability to entrap lipophilic drugs such as GdAcAc with high efficiency, suggested that these systems may have potential in cell targeting, especially for specific delivery to tumor cells for NCT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12026224     DOI: 10.1081/ddc-120002847

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  12 in total

1.  In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles.

Authors:  Paul R Lockman; Joanna Koziara; Karen E Roder; Jennifer Paulson; Thomas J Abbruscato; Russell J Mumper; David D Allen
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

2.  Contributory roles of innate properties of cetyl alcohol/gelucire nanoparticles to antioxidant and anti-inflammation activities of quercetin.

Authors:  Lipeng Bi; Daniel Wehrung; Moses O Oyewumi
Journal:  Drug Deliv Transl Res       Date:  2013-08       Impact factor: 4.617

3.  In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain.

Authors:  S Rahima Benhabbour; J Christopher Luft; Dongwook Kim; Anekant Jain; Saurabh Wadhwa; Matthew C Parrott; Rihe Liu; Joseph M DeSimone; Russell J Mumper
Journal:  J Control Release       Date:  2011-10-20       Impact factor: 9.776

4.  Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles.

Authors:  J M Koziara; J J Oh; W S Akers; S P Ferraris; R J Mumper
Journal:  Pharm Res       Date:  2005-08-26       Impact factor: 4.200

5.  Preparation and characterization of nickel nanoparticles for binding to his-tag proteins and antigens.

Authors:  Jigna D Patel; Ronan O'Carra; Julia Jones; Jerold G Woodward; Russell J Mumper
Journal:  Pharm Res       Date:  2006-12-19       Impact factor: 4.200

6.  Mixed polyethylene glycol-modified breviscapine-loaded solid lipid nanoparticles for improved brain bioavailability: preparation, characterization, and in vivo cerebral microdialysis evaluation in adult Sprague Dawley rats.

Authors:  Zhidong Liu; Chukwunweike Ikechukwu Okeke; Li Zhang; Hainan Zhao; Jiawei Li; Mike Okweesi Aggrey; Nan Li; Xiujun Guo; Xiaochen Pang; Lili Fan; Lili Guo
Journal:  AAPS PharmSciTech       Date:  2014-01-31       Impact factor: 3.246

7.  Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging.

Authors:  Erica Andreozzi; Jai Woong Seo; Katherine Ferrara; Angelique Louie
Journal:  Bioconjug Chem       Date:  2011-03-09       Impact factor: 4.774

8.  Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia.

Authors:  Ping Ma; Xiaowei Dong; Courtney L Swadley; Anshul Gupte; Markos Leggas; Harry C Ledebur; Russell J Mumper
Journal:  J Biomed Nanotechnol       Date:  2009-04       Impact factor: 4.099

9.  Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization.

Authors:  Xiaowei Dong; Cynthia A Mattingly; Michael Tseng; Moo Cho; Val R Adams; Russell J Mumper
Journal:  Eur J Pharm Biopharm       Date:  2008-12-10       Impact factor: 5.571

Review 10.  A critical review of lipid-based nanoparticles for taxane delivery.

Authors:  Lan Feng; Russell J Mumper
Journal:  Cancer Lett       Date:  2012-07-13       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.